NCT01836835

Brief Summary

Nausea in early pregnancy (emesis gravidarum) is very common but most often self-limiting. Hyperemesis gravidarum; where nausea and vomiting is severe and protracted is potentially dangerous for the woman and her foetus and necessitates hospital treatment. An English questionnaire (PUQE; Pregnancy Unique Questionnaire of Emesis) exists that can differentiate between uncomplicated emesis and the severe hyperemesis condition. This questionnaire has been translated to Norwegian. The investigators want to test the ability of this questionnaire to differentiate the grade of nausea/vomiting between a group of presumed normal pregnant woman and patients treated for hyperemesis gravidarum in a Norwegian population. The investigators also want to relate the PUQE questionnaire scoring to the women/patients' self-reported nutritional intake during 24 hours.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
69

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2013

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 8, 2013

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 22, 2013

Completed
9 days until next milestone

Study Start

First participant enrolled

May 1, 2013

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2015

Completed
Last Updated

March 30, 2015

Status Verified

March 1, 2015

Enrollment Period

11 months

First QC Date

April 8, 2013

Last Update Submit

March 27, 2015

Conditions

Keywords

Hyperemesis gravidarumPregnancyNauseaNutritional statusQuestionnaireCase-control

Outcome Measures

Primary Outcomes (1)

  • Pregnancy Unique Questionnaire of Emesis (PUQE) score reported by hyperemesis patients versus normal pregnant women

    Pregnancy Unique Questionnaire of Emesis (PUQE) score range from 3 to 15. Scores reported for the first 24 hours after inclusion will be compared between hyperemesis patients and healthy pregnant control women

    24 hours after inclusion

Secondary Outcomes (1)

  • Pregnancy Unique Questionnaire of Emesis (PUQE) score in relation to self reported 24 hours nutritional intake registration (estimated caloric intake)in hyperemesis patients versus normal pregnant women

    24 hours after inclusion

Other Outcomes (4)

  • Change in Pregnancy Unique Questionnaire of Emesis (PUQE) score from hospital admittance to discharge

    From hospital admission to discharge, mean 7 days

  • Pregnancy Unique Questionnaire of Emesis (PUQE) score at inclusion related to change in patient weight (kg)from start of pregnancy to inclusion for hyperemesis patients versus normal pregnant women

    From pre-pregnancy to inclusion (mean 9 weeks pregnancy length)

  • Change of Pregnancy Unique Questionnaire of Emesis (PUQE) score and patient weight (kg)

    From inclusion to delivery (mean 7 months)

  • +1 more other outcomes

Study Arms (2)

Hyperemesis gravidarum

Women diagnosed with hyperemesis gravidarum admitted to hospital Pregnancy Unique Questionnaire of Emesis (PUQE) and 24 hours self-reported nutritional intake form administered

Other: Pregnancy Unique Questionnaire of Emesis (PUQE)Other: 24 hours self-reported nutritional intake form

Healthy pregnant women

Women with presumed normal pregnancy Pregnancy Unique Questionnaire of Emesis (PUQE) and 24 hours self-reported nutritional intake form administered

Other: Pregnancy Unique Questionnaire of Emesis (PUQE)Other: 24 hours self-reported nutritional intake form

Interventions

For hyperemesis gravidarum patients the Pregnancy Unique Questionnaire of Emesis (PUQE) (3 questions regarding the amount of nausea and vomiting during 24 hours) will be answered both at hospital admittance and discharge. For control patients the questionnaire will be answered at inclusion.

Healthy pregnant womenHyperemesis gravidarum

A nutritional intake form where relevant food and liquid items can be checked prospectively after consummation during 24 hours. This form will be filled in starting the morning following inclusion.

Healthy pregnant womenHyperemesis gravidarum

Eligibility Criteria

Age16 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Hyperemesis patients; recruited from university hospital clinic (normally 60 patients admitted during 12 months) Control paitients recruited from primary care/private practice out-patient gynaecologists

You may qualify if:

  • Pregnant healthy women (controls)
  • Patients admitted to hospital for hyperemesis gravidarum

You may not qualify if:

  • Unable to understand and read/write Norwegian
  • Conditions other than hyperemesis leading to nausea/vomiting

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Dpt. of Obstetrics and Gynaecology, Haukeland University Hospital

Bergen, Hordaland, 5021, Norway

Location

Dpt Obstetrics Gynaecology, Stavanger University Hospital

Stavanger, Rogaland, 4000, Norway

Location

Related Publications (3)

  • Lacasse A, Rey E, Ferreira E, Morin C, Berard A. Validity of a modified Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) scoring index to assess severity of nausea and vomiting of pregnancy. Am J Obstet Gynecol. 2008 Jan;198(1):71.e1-7. doi: 10.1016/j.ajog.2007.05.051.

    PMID: 18166311BACKGROUND
  • Koren G, Piwko C, Ahn E, Boskovic R, Maltepe C, Einarson A, Navioz Y, Ungar WJ. Validation studies of the Pregnancy Unique-Quantification of Emesis (PUQE) scores. J Obstet Gynaecol. 2005 Apr;25(3):241-4. doi: 10.1080/01443610500060651.

    PMID: 16147725BACKGROUND
  • van Stuijvenberg ME, Schabort I, Labadarios D, Nel JT. The nutritional status and treatment of patients with hyperemesis gravidarum. Am J Obstet Gynecol. 1995 May;172(5):1585-91. doi: 10.1016/0002-9378(95)90501-4.

    PMID: 7755076BACKGROUND

MeSH Terms

Conditions

Hyperemesis GravidarumNausea

Condition Hierarchy (Ancestors)

Morning SicknessPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesVomitingSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jone Trovik, MD, PhD

    Haukeland University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
9 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 8, 2013

First Posted

April 22, 2013

Study Start

May 1, 2013

Primary Completion

April 1, 2014

Study Completion

January 1, 2015

Last Updated

March 30, 2015

Record last verified: 2015-03

Locations